Prosecution Insights
Last updated: April 19, 2026

Examiner: MAHADEVAN, JANAKI ANANTH

Tech Center 1600 • Art Units: 1693

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-60.0% vs TC avg
6
Total Applications
Interview Lift
1175
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
13.9%
§102 Novelty
30.6%
§103 Obviousness
22.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18453835 METHODS FOR PROVIDING HEALTH BENEFITS IN ANIMALS Non-Final OA Société des Produits Nestlé S.A.
18456374 SOFT CHEWABLE FORMULATIONS WITH ACTIVE INGREDIENTS Non-Final OA Noble Pharma, LLC
18365528 HYALURONAN-NIMESULIDE CONJUGATE FOR TREATING LOCALLY ADVANCED OR METASTATIC TUMORS Final Rejection Aihol Corporation
17843534 USES OF HYALURONAN CONJUGATE Non-Final OA Aihol Corporation

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month